Literature DB >> 427123

Design of potent and specific inhibitors of carboxypeptidases A and B.

M A Ondetti, M E Condon, J Reid, E F Sabo, H S Cheung, D W Cushman.   

Abstract

The combination in one molecule of functional groups that can interact specifically with different substrate binding areas at the active site of carboxypeptidases A and B has led to the development of potent and specific inhibitors of these enzymes. 2-Benzyl-3-mercaptopropanoic acid (SQ 14,603) has a Ki of 1.1 x 10(-8) M vs. carboxypeptidase A and a Ki of 1.6 x 10(-4) M vs. the B enzyme. 2-Mercaptomethyl-5-guanidinopentanoic acid (SQ 24,798) has a Ki of 4 x 10(-10) M vs. carboxypeptidase B and a Ki of 1.2 x 10(-5) M vs. carboxypeptidase A. It is proposed that the sulfhydryl groups of these inhibitors bind to the catalytically important zinc ions of these enzymes, and that, in conjunction with the benzyl and guanidinopropyl side chains, they are responsible for their specificity.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 427123     DOI: 10.1021/bi00575a006

Source DB:  PubMed          Journal:  Biochemistry        ISSN: 0006-2960            Impact factor:   3.162


  14 in total

1.  Ionization states of the complex formed between 2-benzyl-3-phosphonopropionic acid and carboxypeptidase A.

Authors:  U B Goli; D Grobelny; R E Galardy
Journal:  Biochem J       Date:  1988-09-15       Impact factor: 3.857

2.  Crystallographic studies on apocarboxypeptidase A and the complex with glycyl-L-tyrosine.

Authors:  D C Rees; W N Lipscomb
Journal:  Proc Natl Acad Sci U S A       Date:  1983-12       Impact factor: 11.205

3.  Metal-coordinating substrate analogs as inhibitors of metalloenzymes.

Authors:  B Holmquist; B L Vallee
Journal:  Proc Natl Acad Sci U S A       Date:  1979-12       Impact factor: 11.205

4.  Metabolism of bradykinin and angiotensin I by human basilar artery and rabbit aorta.

Authors:  E T Whalley
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1987-05       Impact factor: 3.000

5.  The tumor necrosis factor receptor and human neutrophil function. Deactivation and cross-deactivation of tumor necrosis factor-induced neutrophil responses by receptor down-regulation.

Authors:  B Schleiffenbaum; J Fehr
Journal:  J Clin Invest       Date:  1990-07       Impact factor: 14.808

6.  Isolation of three separate anaphylatoxins from complement-activated human serum.

Authors:  T E Hugli; C Gerard; M Kawahara; M E Scheetz; R Barton; S Briggs; G Koppel; S Russell
Journal:  Mol Cell Biochem       Date:  1981-12-04       Impact factor: 3.396

7.  Potent inhibition of endopeptidase 24.16 and endopeptidase 24.15 by the phosphonamide peptide N-(phenylethylphosphonyl)-Gly-L-Pro-L-aminohexanoic acid.

Authors:  H Barelli; V Dive; A Yiotakis; J P Vincent; F Checler
Journal:  Biochem J       Date:  1992-10-15       Impact factor: 3.857

8.  3-Phosphonopropionic acids inhibit carboxypeptidase A as multisubstrate analogues or transition-state analogues.

Authors:  D Grobelny; U B Goli; R E Galardy
Journal:  Biochem J       Date:  1985-11-15       Impact factor: 3.857

9.  In vitro inhibition of Pseudomonas aeruginosa elastase by metal-chelating peptide derivatives.

Authors:  E Kessler; M Israel; N Landshman; A Chechick; S Blumberg
Journal:  Infect Immun       Date:  1982-11       Impact factor: 3.441

10.  Reactivity of reverse transcriptase toward (s4U,U)n copolymers and spin-labeled nucleic acid lattices.

Authors:  P E Warwick; A Hakam; E V Bobst; A M Bobst
Journal:  Proc Natl Acad Sci U S A       Date:  1980-08       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.